PTH hypersecretion triggered by a GABAB1 and Ca2+-sensing receptor heterocomplex in hyperparathyroidism-Reference-Cited by-同舟云学术

PTH hypersecretion triggered by a GABAB1 and Ca2+-sensing receptor heterocomplex in hyperparathyroidism

Published:2020-03 Issue:3 Volume:2 Page:243-255
ISSN:2522-5812
Container-title:Nature Metabolism
language:en
Short-container-title:Nat Metab

Author:

Chang Wenhan^ORCID,Tu Chia-Ling,Jean-Alphonse Frederic G.,Herberger Amanda,Cheng Zhiqiang,Hwong Jenna,Ho Hanson,Li Alfred,Wang Dawei,Liu Hongda,White Alex D.,Suh Insoo^ORCID,Shen Wen,Duh Quan-Yang,Khanafshar Elham,Shoback Dolores M.,Xiao Kunhong,Vilardaga Jean-Pierre^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Physiology (medical),Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.nature.com/articles/s42255-020-0175-z.pdf

Reference45 articles.

1. Hannan, F. M., Kallay, E., Chang, W., Brandi, M. L. & Thakker, R. V. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat. Rev. Endocrinol. 15, 33–51 (2018).

2. Conigrave, A. D. & Ward, D. T. Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways. Best Pract. Res. Clin. Endocrinol. Metab. 27, 315–331 (2013).

3. Bandeira, F. et al. Bone disease in primary hyperparathyroidism. Arq. Bras. Endocrinol. Metabol. 58, 553–561 (2014).